What is the recommended treatment for uncomplicated genital Chlamydia trachomatis infection?

Treatment of Uncomplicated Genital Chlamydia Trachomatis Infection

For uncomplicated genital chlamydia, treat with either doxycycline 100 mg orally twice daily for 7 days OR azithromycin 1 g orally as a single dose—both are equally effective, but choose doxycycline when compliance is assured and azithromycin when directly observed therapy is needed. 1

First-Line Treatment Options

The two recommended regimens have equivalent efficacy based on clinical trials:

• Doxycycline 100 mg orally twice daily for 7 days
• Azithromycin 1 g orally as a single dose

Both cure infection and relieve symptoms with similar efficacy rates (>95%) 2, 1. The choice between them depends on practical considerations rather than efficacy differences.

When to Choose Doxycycline

• Lower cost than azithromycin
• Longer track record of safety and efficacy
• Patient has reliable follow-through with 7-day regimens
• No concerns about medication adherence 1

When to Choose Azithromycin

• Single-dose directly observed therapy is critical—this is the key advantage
• Patients with erratic healthcare-seeking behavior
• Concerns about treatment compliance
• Populations with unpredictable follow-up 3, 1

The most recent European guideline (2025) recommends doxycycline as first-line in preference to azithromycin 4, though both remain acceptable options in CDC guidelines.

Alternative Regimens

If neither first-line option is suitable:

• Levofloxacin 500 mg orally once daily for 7 days 1
• Ofloxacin 300 mg orally twice daily for 7 days 1
• Erythromycin base 500 mg orally four times daily for 7 days 1
• Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days 1

Important caveats: Erythromycin is less efficacious than doxycycline or azithromycin, primarily because gastrointestinal side effects reduce compliance 1. The quinolones (levofloxacin, ofloxacin) are more expensive and offer no dosing advantage over doxycycline 1.

Special Populations

Pregnancy

Doxycycline and quinolones are absolutely contraindicated in pregnancy. 2

For pregnant women, use:

• Erythromycin base 500 mg orally four times daily for 7 days (preferred) 2
• Alternative: Erythromycin base 250 mg orally four times daily for 14 days
• Alternative: Erythromycin ethylsuccinate 800 mg orally four times daily for 7 days
• Alternative: Amoxicillin 500 mg orally three times daily for 7-10 days (if erythromycin not tolerated) 2

Never use erythromycin estolate in pregnancy—it causes drug-related hepatotoxicity. 2

Repeat testing after treatment is recommended in pregnancy due to limited efficacy data for these regimens and frequent gastrointestinal side effects that reduce compliance 2.

HIV-Infected Patients

Treat identically to HIV-negative patients—no modification needed 1

Critical Management Points

Medication Dispensing

Dispense medications on-site and directly observe the first dose to maximize compliance 1. This is particularly important for azithromycin's single-dose regimen.

Sexual Abstinence

Instruct patients to abstain from sexual intercourse for 7 days after single-dose therapy OR until completion of a 7-day regimen 1. This minimizes transmission risk.

Partner Management

• Evaluate and treat sex partners who had contact within 60 days preceding diagnosis 5
• Treat the most recent partner even if contact was >60 days ago 5
• Partners should receive the same treatment as the index patient
• Consider expedited partner therapy (providing medication/prescription to patient for their partner) if standard referral is impractical 5

Follow-Up Testing

Test-of-cure is NOT routinely recommended after treatment with doxycycline or azithromycin unless:

• Symptoms persist
• Reinfection is suspected
• Therapeutic compliance is questionable
• Patient is pregnant 1, 5

Testing <3 weeks after treatment can yield false-positive results from dead organisms or false-negative results from low organism numbers 1.

However, retest approximately 3 months after treatment to detect reinfection, which occurs frequently and increases PID risk 5. This is distinct from test-of-cure and addresses the high reinfection rates observed in treated populations.

Common Pitfalls to Avoid

1. Don't test too early post-treatment—wait at least 3 weeks to avoid false results 1
2. Don't use quinolones in pregnancy or patients ≤17 years old 2
3. Don't forget to treat partners—untreated partners are the primary source of reinfection 5
4. Don't assume compliance—when in doubt, use single-dose azithromycin with direct observation 1
5. Don't skip the 3-month retest—reinfection rates are high and increase morbidity risk 5